Gout and the risk of acute myocardial infarction

Arthritis and Rheumatism

Volumn 54, Issue 8, 2006, Pages 2688-2696

  Krishnan, Eswar ^a   Baker, Joshua F ^b   Furst, Daniel E ^c   Schumacher, H Ralph ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GOUT; HUMAN; HYPERURICEMIA; INSTRUMENTAL VARIABLE PROBIT REGRESSION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

ARTHRITIS, GOUTY; DIURETICS; HUMANS; HYPERURICEMIA; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PENNSYLVANIA; RISK FACTORS;

EID: 33747043614     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22014     Document Type: Article

References (36)

1. Roberts W. Gout. In: Allbutt TC, editor. A system of medicine, by many writers. London: Macmillan; 1897. p. 160.
2. Benedek TG. Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men. Ann Intern Med 1967;66:851-61.
3. Benedek TG, Sunder JH. Comparisons of serum lipid and uric acid content in white and Negro men. Am J Med Sci 1970;260:331-40.
4. Ask-Upmark E, Adner L. Coronary infarction and gout. Acta Med Scand 1950;139:1-6.
5. Gardner MJ, Power C, Barker DJ, Padday R. The prevalence of gout in three English towns. Int J Epidemiol 1982;11:71-5.
6. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147-53.
7. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26.
8. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005;143:499-516.
9. Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J 2005;150:11-8.
10. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol l988;41:237-42.
11. Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, et al. Gout and risk for subsequent coronary heart disease: the Meharry-Hopkins Study. Arch Intern Med 1997;157:1436-40.
12. Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract 2003;20:413-6.
13. The Multiple Risk Factor Intervention Trial Group. Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). J Chronic Dis 1977;30:261-75.
14. Multiple Risk Factor Intervention Trial Research Group. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986;58:1-13.
15. Benfari RC. The multiple risk factor intervention trial (MRFIT). III. The model for intervention. Prev Med 1981;10:426-42.
16. Schlesinger N, Schumacher HR Jr. Update on gout. Arthritis Rheum 2002;47:563-5.
17. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61.
18. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
19. Norton EC, Lindrooth RC, Ennett ST. Controlling for the endogeneity of peer substance use on adolescent alcohol and tobacco use. Health Econ 1998;7:439-53.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
21. Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 1991;34:141-5.
22. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999;10 Suppl 1:59-12.
23. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
24. Crea F, Biasucci LM, Buffon A, Liuzzo G, Monaco C, Caligiuri G, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease [review]. Am J Cardiol 1997;80:10E-16E.
25. Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in corcmary artery disease. Heart 2006;92:441-4.
26. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17.
27. Kao AH, Sabatine JM, Manzi S. Update on vascular disease in systemic lupus erythematosus. Curr Opin Rheumatol 2003;15:519-27.
28. Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774-9.
29. Talbott J. Symposium on gout. Metabolism 1957;1:193-5.
30. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 1993;270:354-9.
31. Frohlich ED. Uric acid: a risk factor for coronary heart disease. JAMA 1993;270:378-9.
32. Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA 1991;266:3004-7.
33. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99-106.
34. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
35. Shaper AG. Alcohol and mortality: a review of prospective studies. Br J Addict 1990;85:837-47.
36. Krishnan E, Griffith C, Kwoh K. Burden of illness from gout in ambulatory care in the United States [abstract]. Arthritis Rheum 2005;52 Suppl 9:S656.